Combined Omeprazole and

Sahar Khateeb, Mody Albalawi, Amnah Obidan, Fahad M Almutairi, Hanan Abdulrahman Sagini, Eman F S Taha

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sahar KhateebDepartment of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0002-1524-7247

Mody AlbalawiDepartment of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0009-0009-4955-5705

Amnah ObidanDepartment of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0009-0003-9249-3649

Fahad M AlmutairiDepartment of Biochemistry, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia.

Hanan Abdulrahman SaginiDepartment of Biological Sciences, College of Sciences, University of Jeddah, Jeddah 21959, Saudi Arabia.ORCID 0000-0002-2613-7553

Eman F S TahaHealth Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority (EAEA), Cairo 11787, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ethanol (EtOH)-induced gastric ulcer (GU) is a common model used to investigate mechanisms of mucosal injury and repair. Omeprazole (OMP) is a conventional anti-ulcer drug that effectively suppresses gastric acid secretion, but its efficacy may be enhanced by combining it with bioactive phytochemicals derived from a

Indexed as

GlycyrrhizaOmeprazolePlant ExtractsStomach UlcerAnimalsAnti-Ulcer AgentsEthanolGastric MucosaMaleNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsRats, WistarSignal TransductionAnti-Ulcer AgentsEthanolmTOR protein, ratNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratOmeprazolePhosphatidylinositol 3-KinasesPlant ExtractsProto-Oncogene Proteins c-aktTlr4 protein, ratToll-Like Receptor 4TOR Serine-Threonine KinasesGlycyrrhiza glabra L.inflammationomeprazoleoxidative stressulcer

Identifiers

PMID42589688

DOI10.3390/ijms27157037

PMCPMC13466849

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.